MedDRA and WHO Drug licenses are very expensive. Do you provide the dictionaries?
The license agreements for both MedDRA and WHO Drug prevent us from giving coded data to another company unless that company also holds a valid dictionary license. So even if ThesIS is doing your coding and/or versioning, you will still need to have current licenses for MedDRA and/or WHO Drug. For MedDRA, the good news is that the license fees have been significantly reduced (especially for smaller companies), so the cost should no longer be an issue. For WHO Drug, small sponsor companies (yearly revenue less than US$10 million) who are conducting only phase 1 or phase 2 clinical trials may qualify for a “Limited Study License for Sponsors.” The price for a Limited Study License is significantly less than for a full WHO Drug license. Please contact us to learn more about this license option and the conditions needed to qualify for it.
